BRCA2 and breast carcinoma: A meta-analysis of cumulative risks for contralateral breast cancer in BRCA1/2 mutation carriers with a first breast cancer showed a cumulative 10-year incidence rate of 27% and 19% for contralateral breast cancer in BRCA1 and BRCA2 mutation carriers, respectively [21].